ClinConnect ClinConnect Logo
Search / Trial NCT05736302

Validating a New Machine-Learned Accelerometer Algorithm Using Doubly Labeled Water

Launched by UNIVERSITY OF WISCONSIN, MILWAUKEE · Feb 15, 2023

Trial Information

Current as of July 27, 2025

Recruiting

Keywords

Doubly Labeled Water (Dlw) Total Daily Energy Expenditure (Tdee) Accelerometry

ClinConnect Summary

This clinical trial is studying a new way to measure how much energy people use in their daily activities. Researchers want to see if a special computer program, which uses data from an accelerometer (a device that tracks movement), can accurately estimate the total daily energy expenditure (TDEE) in individuals who have movement and functional limitations. This could help improve understanding of energy use in people with different movement disorders.

To participate in the trial, you need to be at least 18 years old and able to walk on your own without help. You'll also need to be comfortable using a smartphone and a computer since these will be important for the study. If you have certain medical conditions, like uncontrolled high blood pressure or if you rely on a wheelchair or other walking aids, you may not be eligible. Participants will be asked to take part in specific activities to help test the accuracy of the new program, and the research team will provide guidance throughout the process. If you’re interested in learning more or think you might be eligible, feel free to reach out for more information!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • must be 18+ years of age
  • be able to ambulate on own, unassisted, on a regular basis
  • speak and read English
  • must have access to a working smart phone and a computer with internet access
  • Exclusion Criteria:
  • wheelchair reliant
  • assistive walking device reliant (cannot walk for at least 50 feet without an assistive device)
  • diagnosed uncontrolled hypertension (above 160/100 mgHg)
  • diagnosed cognitive impairment or inability to follow study procedures such as Alzheimer's disease or dementia
  • cannot take metabolic altering medications
  • cannot be pregnant
  • cannot be breastfeeding
  • cannot use supplemental oxygen
  • cannot completed required study activities for any reason
  • cannot have a resting heart rate \> 100 bpm or a resting blood pressure \> 160 mgHg during Visit 1
  • cannot weigh more than 450 lbs

About University Of Wisconsin, Milwaukee

The University of Wisconsin-Milwaukee (UWM) is a leading research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, UWM leverages its diverse expertise in biomedical research, public health, and community engagement to conduct rigorous clinical studies. The university fosters an environment of academic excellence and ethical research practices, aiming to translate findings into real-world applications that benefit patients and communities. UWM is committed to enhancing the quality of life through scientific discovery and education, making significant contributions to the field of clinical research.

Locations

Milwaukee, Wisconsin, United States

Patients applied

0 patients applied

Trial Officials

Scott Strath, PhD

Principal Investigator

University of Wisconsin, Milwaukee

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials